Actron orudis where to buy

Case Files Collection. Clinical Sports Medicine Collection. Davis AT Collection. Davis PT Collection. Murtagh Collection. All Sites F. About Search. Enable Autosuggest. You have successfully created a MyAccess Profile for alertsuccessName. Previous Chapter. Next Chapter. AMA Citation Ketoprofen. In: Ciccone CD.

Ciccone C. Charles D. Davis's Drug Guide for Rehabilitation Professionals. McGraw Hill; Accessed November 12, PrescriptionGiant does not charge you membership fees or collect your personal information. Click the CARD below to print or take a screenshot on your mobile phone or tablet. There is no need to download another app!

If you would like to personalize your card enter your full name in the member name field below the card at this link and click the Update button. People who take nonsteroidal anti-inflammatory drugs NSAIDs other than aspirin, such as ketoprofen, may have a higher risk of having a heart attack or a stroke than people who do not take these medications.

These events may happen without warning and may cause death. Do not take an NSAID such as ketoprofen if you have recently had a heart attack, unless directed to do so by your doctor. Tell your doctor if you or anyone in your family has or has ever had heart disease, a heart attack, or a stroke, if you smoke, and if you have or have ever had high cholesterol, high blood pressure, or diabetes. Get emergency medical help right away if you experience any of the following symptoms: chest pain, shortness of breath, weakness in one part or side of the body, or slurred speech.

If you will be undergoing a coronary artery bypass graft CABG; a type of heart surgery , you should not take ketoprofen right before or right after the surgery. NSAIDs such as ketoprofen may cause ulcers, bleeding, or holes in the stomach or intestine. These problems may develop at any time during treatment, may happen without warning symptoms, and may cause death.

The risk may be higher for people who take NSAIDs for a long time, are older in age, have poor health, or drink more than three alcoholic drinks per day while taking ketoprofen.

Also tell your doctor if you have or have ever had ulcers or bleeding in your stomach or intestines or other bleeding disorders. If you experience any of the following symptoms, stop taking ketoprofen and call your doctor: stomach pain, heartburn, vomit that is bloody or looks like coffee grounds, blood in the stool, or black and tarry stools.

Keep all appointments with your doctor and the laboratory. Be sure to tell your doctor how you are feeling so that your doctor can prescribe the right amount of medication to treat your condition with the lowest risk of serious side effects.

Read the information carefully and ask your doctor or pharmacist if you have any questions. Prescription ketoprofen is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis arthritis caused by a breakdown of the lining of the joints and rheumatoid arthritis arthritis caused by swelling of the lining of the joints. Prescription ketoprofen capsules are also used to relieve pain, including menstrual pain pain that occurs before or during a menstrual period.

Consider avoiding concurrent use in CHF or cirrhosis. Concomitant use of bumetanide with indomethacin is not recommended.

Macimorelin: Nonsteroidal Anti-Inflammatory Agents may diminish the diagnostic effect of Macimorelin. Methotrexate: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Methotrexate. Management: Alternative anti-inflammatory therapy should be considered whenever possible, especially if the patient is receiving higher, antineoplastic doses of methotrexate.

Mifamurtide: Nonsteroidal Anti-Inflammatory Agents may diminish the therapeutic effect of Mifamurtide. Specifically, the risk of serious bleeding-related events may be increased. Specifically, the risk for bleeding-related events may be increased. Specifically, the risk of bleeding may be increased by concurrent use of these agents.

Pentoxifylline: May enhance the antiplatelet effect of Agents with Antiplatelet Properties. Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer. Nonsteroidal Anti-Inflammatory Agents may also enhance the therapeutic effects of Prostaglandins Ophthalmic.

Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Quinolones. Management: A comprehensive risk to benefit assessment should be done for all patients before any concurrent use of rivaroxaban and nonsteroidal anti-inflammatory drugs NSAIDs.

An increased risk of bleeding may be associated with use of this combination. Nonsteroidal Anti-Inflammatory Agents Nonselective may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of Nonsteroidal Anti-Inflammatory Agents Nonselective. Exceptions: Choline Magnesium Trisalicylate. Increased risk of bleeding may result. Monitor for evidence of bleeding and diminished antidepressant effects. Management: Consider discontinuing drugs that may affect gallbladder motility prior to the use of sincalide to stimulate gallbladder contraction.

Specifically, the risk of acute phosphate nephropathy may be enhanced. Management: Consider avoiding this combination by temporarily suspending treatment with NSAIDs, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, maintain adequate hydration and monitor renal function closely. Management: Seek alternatives to these combinations whenever possible.

Tipranavir: May enhance the antiplatelet effect of Agents with Antiplatelet Properties. Specifically, the risk of hypersensitivity reactions may be increased. Tolperisone may enhance the therapeutic effect of Nonsteroidal Anti-Inflammatory Agents. Urokinase: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Urokinase.

Vancomycin: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Vancomycin. Verteporfin: Photosensitizing Agents may enhance the photosensitizing effect of Verteporfin.

Management: Consider alternatives to this combination when possible. If the combination must be used, monitor coagulation status closely and advise patients to promptly report any evidence of bleeding or bruising. Zanubrutinib: May enhance the antiplatelet effect of Agents with Antiplatelet Properties. Presence of ketoprofen and its metabolites in urine may interfere with certain tests used to detect albumin, bile salts, ketosteroids or hydroxycorticosteroids in urine and that rely upon acid precipitation as an end point or upon color reactions for carbonyl groups.

Ketoprofen crosses the placenta Bannwarth Dysmenorrhea, menstrual cramps or painful periods is the commonest menstrual disorder. The causes are varied. Treatment aims at providing pain relief. Show More Related Topics. Disclaimer - All information and content on this site are for information and educational purposes only.

The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer. This site complies with the HONcode standard for trustworthy health information: verify here. Information about drug Ketoprofen includes cost of the drug and the type of drug - tablet, capsule, syrup, cream, gel, ointment, liquid or injection.

To view the price of the drug, click on the brand name. The generic Ketoprofen is manufactured by one company. Medindia's drug directory has currently 17 Brands of Ketoprofen listed.

New generics and brands are constantly being updated as and when they are approved by drug controller and available in the pharmacies.